Profil
Alex Mercer worked as the Director of Clinical Development at Calliditas Therapeutics AB and as the Head of Discovery at Newron Sweden AB from 2000 to 2010.
He holds a doctorate degree from University College London.
Anciens postes connus de Alex Mercer
| Sociétés | Poste | Fin |
|---|---|---|
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | - |
Formation de Alex Mercer
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
